Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion type Assertion NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_head.
- NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_provenance.
- NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion evidence source_evidence_literature NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_provenance.
- NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion SIO_000772 20668229 NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_provenance.
- NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion wasDerivedFrom befree-2016 NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_provenance.
- NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion wasGeneratedBy ECO_0000203 NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_provenance.